Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome.
Correction: A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.
Supportive or detrimental roles of P2Y receptors in brain pathology?-The two faces of P2Y receptors in stroke and neurodegeneration detected in neural cell and in animal model studies.
Proton detection for signal enhancement in solid-state NMR experiments on mobile species in membrane proteins.
Acute effects of varying intensities of treadmill walking exercise on inhibitory control in persons with multiple sclerosis: A pilot investigation.
Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function.
IFN-γ-induced apoptosis of human embryonic stem cell derived oligodendrocyte progenitor cells is restricted by CXCR2 signaling.
Response to: Tocilizumab, neuromyelitis optica (NMO), and multiple sclerosis.
Health literacy association with health behaviors and health care utilization in multiple sclerosis: a cross-sectional study.
LINGO-1 regulates oligodendrocyte differentiation by inhibiting ErbB2 translocation and activation in lipid rafts.
Support our campaign for better treatment for people with MS.
The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.
Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study.
Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course.
Movement disorders in multiple sclerosis and other demyelinating diseases.
Stability of rating scale response category interpretations in neurological disorders.
Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology.
Localized grey matter atrophy in multiple sclerosis: A meta-analysis of voxel-based morphometry studies and associations with functional disability.
Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures.
[PET-patterns of cognitive impairment in patients with multiple sclerosis.]
Diagnostic criteria for pediatric multiple sclerosis.
[Progressive multifocal leukoencephalopathy as a complication of natalizumab therapy].

Pages